Patent · US Active

In vitro method for the detection and quantification of HIV-2

US10385410B2 · kind B2 · utility

1Cited by

2References

12Claims

0Family size

Assignees

UNIVERSITE DE PARIS DESCARTES · FR
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
CHU DE ROUEN · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITE DE ROUEN · FR
Université Paris Diderot · FR

Inventors

Christine Rouzioux · Paris, FR
Jean-Christophe Plantier · Bois-Guillaume, FR
Véronique Avettand-Fenoel · Paris, FR
Florence Damond · Poitiers, FR
Marie Gueudin · Rouen, FR
Diane Descamps · Paris, FR

Key dates

Filing date	May 27, 2015
Grant date	Aug 20, 2019
Priority date	—
Expiry date	May 27, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a method for detecting or quantifying Human Immunodeficiency Virus-2 (HIV-2) nucleic acids in a biological sample, comprising: a) performing a real-time polymerase chain reaction (PCR) or a real-time reverse transcriptase polymerase chain reaction (RT-PCR) on nucleic acids of the biological sample with: (i) at least 4 primers respectively comprising or consisting of:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.